NIH-funded research U01 cooperative agreement

Cannabidiol (CBD) to reduce opioid use after knee replacement

Official title: Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)

Funded at University of Michigan at Ann Arbor · NIH-11192350 · Data updated 2026-11-12

This trial will see if taking cannabidiol (CBD) around the time of a knee replacement helps people use fewer opioid pain medicines after surgery.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 18, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$1,109,271
NIH project number5U01AR083132-03
Project IDNIH-11192350 on NIH RePORTER

Who could benefit from this research

Could help

Adults scheduled for primary total knee arthroplasty who can take CBD and agree to study visits and medication reporting are ideal candidates.

Less likely to help

People not having knee replacement, those with medical reasons to avoid cannabinoids, or those already dependent on high-dose opioids may not benefit from this trial.

What this research studies

You would be randomly assigned to receive CBD or a placebo in a 2x2 factorial, double-blind design so neither you nor the staff know which treatment you get. The team will track how much opioid medication you use, your pain levels, side effects, and recovery after your primary total knee arthroplasty. Visits and monitoring happen around the time of surgery and during recovery to collect medication use and symptom reports. The goal is to learn whether adding CBD can safely lower opioid needs after knee replacement.

Why it matters

Potential benefit: If successful, CBD could reduce how much opioid medication people need after knee replacement, lowering side effects and the risk of long-term opioid dependence.

How similar studies have gone: Some animal studies and small human reports suggest CBD can reduce pain, anxiety, and opioid craving, but rigorous randomized trials for postoperative opioid reduction are limited.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Brummett, Chad M — University of Michigan at Ann Arbor
  • Study coordinator: Brummett, Chad M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.